Chlamydia pneumoniae, asthma, and COPD: What is the evidence?

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 4, 1999, Pages 271-288

  Hahn, David L ^a,b  

^a DEAN MEDICAL CENTER   (United States)

^b Arcand Park Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN E; SECRETORY IMMUNOGLOBULIN;

ANTIBIOTIC THERAPY; ASTHMA; BACTERIUM DETECTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; LIFE CYCLE; LUNG INFECTION; NONHUMAN; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY;

EID: 0032746207     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62666-X     Document Type: Article

References (167)

1. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-763.
2. Hahn DL. Intracellular pathogens and their role in asthma: Chlamydia pneumoniae in adult patients. Eur Respir Rev 1996;6: 224-230.
3. von Hertzen L. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med 1998;30:27-37.
4. Thomas WS. Asthma: its diagnosis and treatment. New York: Paul B Hoeber, 1928:279.
5. Chobot R, Uvitsky IH, Dundy H. The relationship of the etiologic factors in asthma in infants and children. J Allergy 1951;22: 106-110.
6. Fox JL. Infectious asthma treated with triacetyloleandomycin. Penn Med J 1961;64: 634-635.
7. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services. Public Health Service. National Institutes of Health, National Heart, Lung, and Blood Institute. February 1997.
8. Smith JM. Asthma and atopy as diseases of unknown cause. A viral hypothesis possibly explaining the epidemiologic association of the atopic diseases and various forms of asthma. Ann Allergy 1994;72:156-162.
9. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138.
10. Hogg JC. Adenoviral infection and childhood asthma. Am J Respir Crit Care Med 1994;150:2-3.
11. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998;158:998-1001.
12. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148: 727-732.
13. Hahn DL. Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 1995;41:345-351.
14. Hahn D, Bukstein D, Luskin A, et al. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 1998;80:45-49.
15. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae infection initiate chronic asthma? Ann Allergy Asthma Immunol 1998;81:339-344.
16. Allegra L, Blasi F, Centanni S, et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 1994;7:2165-2168.
17. Ward ME. The chlamydial developmental cycle. In: Barron AL, eds. Microbiology of chlamydia. Boca Raton, Florida: CRC Press, Inc, 1988:71-95.
18. Kuo C-c. Chlamydia as pathogens. Host response. In: Barron AL, eds. Microbiology of chlamydia. Boca Raton, Florida: CRC Press, Inc, 1988:193-208.
19. Rank R. Chlamydia as pathogens. Role of the immune response. In: Barron AL, eds. Microbiology of chlamydia. Boca Raton, Florida: CRC Press, Inc, 1988:217-234.
20. Beatty WL, Morrison RP, Byrne G. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994;58:686-699.
21. Mehta SJ, Miller RD, Ramirez JA, et al. Inhibition of Chlamydia pneumoniae replication in HEP-2 cells by interferon-gamma: role of tryptophan catabolism. J Infect Dis 1998;177:1326-1331.
22. Matsumoto A, Manire GP. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol 1970;101:278-285.
23. Mabey DCW, Hampton TJ, Hayes LJ, et al. The detection of ocular chlamydial infection in trachoma using the polymerase chain reaction. In: Orfila J, Byrne GI, Chernesky MA, et al, eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994: 318-321.
24. Campbell LA, Patton DL, Moore DE. et al. Detection of chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril 1993;59:45-50.
25. Peeling RW, Bailey RL, Conway DJ, et al. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis 1998;177:256-259.
26. Peeling RW, Kimani J, Plummer F, et al. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 1997;175: 1153-1158.
27. Holland MJ, Bailey RL, Conway DJ, et al. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996;105: 429-435.
28. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14: 178-182.
29. Grayston JT, Kuo C-c, Campbell LA, et al. Chlamydia pneumoniae and cardiovascular disease. Cardiologia 1997;42:1145-1151.
30. Numazaki K, Chiba S. Serum gamma-interferon in patients with pneumonia caused by Chlamydia pneumoniae. Pediatr Infect Dis J 1996;15:174-175.
31. Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98:300-307.
32. Friedland JS. Host resistance and Mycobacterium tuberculosis infection. In: Paradise LJ, Friedman H, Bendinelli M, eds. Opportunistic intracellular bacteria and immunity. New York: Plenum Press, 1999:37-54.
33. Kimura M. Experimental study on the mechanisms of Chlamydia pneumoniae respiratory infection in mice with former chlamydial exposure. Jpn Assoc Infect Dis 1994;68:50-58.
34. Yang Z-p, Cummings PK, Patton DL, et al. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1994;170:464-467.
35. Kishimoto T. Studies on chlamydia pneumoniae, strain TWAR, infection. I. Experimental infection of C. pneumoniae in mice and serum antibodies against TWAR by MFA [Jpn]. J Jpn Assoc Infect Dis 1990;64: 124-131.
36. Laitinen K, Laurila A, Leinonen M, et al. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive protection by immune serum. In: Orfila J, Byrne GI, Chernesky MA, et al eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994:545-548.
37. Malinverni R, Kuo C-c, Campbell LA, et al. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis 1995;172:593-594.
38. Kaukoranta-Tolvanen S-SE, Laurila AL, Saikku P, et al. Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. Microb Pathogen 1995;18:279-288.
39. Moazed TC, Kuo C-c, Grayston JT, et al. Evidence of systemic dissemination of chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-1325.
40. Moazed TC, Kuo C-c, Patton D, et al. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996;148: 667-676.
41. Laitinen K, Laurila A, Pyhälä L, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-4835.
42. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97: 633-636.
43. Harris JS, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998;17: 865-871.
44. Hammerschlag MR, Roblin PM, Cassell G. Microbiologic efficacy of azithromycin for the treatment of community-acquired lower respiratory tract infection due to Chlamydia pneumoniae. Presented at the Second International Conference on the Macrolides, Azalides and the Streptogramins, Venice, Italy, January 1994.
45. Denny FW, Clyde WA, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 1971;123:74-92.
46. Falck G, Gnarpe J, Gnarpe H. Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 1997;28: 271-273.
47. Black CM, Perez R. Chlamydia pneumoniae multiplies within human pulmonary macrophages. Abstracts of the 90th Annual Meeting of the American Society for Microbiology, 1990;80.
48. Redecke V, Dalhoff K, Bohnet S, et al. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998;19:721-727.
49. Boman J, Söderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998; 178:274-277.
50. Wesslén L, Påhlson C, Friman G, et al. Myocarditis caused by chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 1992;340: 427-428.
51. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53: 100-105.
52. Haidl S, Ivarsson S, Bjerre I, et al. Guillan-Barré syndrome after Chlamydia pneumoniae infection. N Engl J Med 1992;326: 576-577.
53. Michel D, Antoine JC, Pozzetto B, et al. Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection. J Neurol Neurosurg Psychiatry 1992;55:511.
54. Kauppinen M, Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 1995;21:S244-S252.
55. Kauppinen M, Saikku P, Kujala P, et al. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 1996;51:185-189.
56. Blasi F, Cosentini R, Damato S, et al. Chlamydia pneumoniae chronic infection increases the risk of bacterial colonization in chronic bronchitis. Am J Respir Crit Care Med 1997;155(part 2 of 2 parts):A592.
57. DeAbate CA, Henry D, Bensch G, et al. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. Chest 1998;114:120-130.
58. Busse WW. Role and contribution of viral respiratory infections to asthma. Allergy 1993;48:57-64.
59. Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis 1995; 171:1274-1278.
60. Kishimoto T, Nakajima M, Nakagawa Y, et al. A case of pneumonia caused by Chlamydia pneumoniae, strain TWAR. J Jpn Assoc Infect Dis 1990;64:510-515.
61. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993;14(Suppl K):56-71.
62. Emre U, Sokolovskaya N, Roblin P, et al. Detection of Chlamydia pneumoniae-IgE in children with reactive airway disease. J Infec Dis 1995;172:265-267.
63. Peeling RW, Hahn D, Dillon E. Chlamydia pneumoniae infection and adult-onset asthma. Proceedings of the Third Meeting of the European Society for Chlamydia Research, Vienna, Austria, Società Editrice Esculapio, Bologna, 1996;228 [abstract].
64. Larsen FO, Norn S, Mordhorst CH, et al. Chlamydia pneumoniae and possible relationship to asthma. Serum immunoglobulins and histamine release in patients and controls. APMIS 1998;106:928-934.
65. Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 1996;117:513-517.
66. Vignola AM, Chanez P, Polla BS, et al. Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol 1995;13: 683-691.
67. Thepen T, McMenamin C, Girn B, et al. Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin Exp Allergy 1992;22:1107-1114.
68. Knoebel E, Vijayagopal P, Fiuero II JE, et al. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun 1997; 65:503-506.
69. Kline JN, Cowden JD, Hunninghake GW, et al. Expression of sensitive or hyporesponsive phenotypes in individuals challenged with inhaled lipopolysaccharide correlates with differential response of alveolar macrophages and monocytes in vitro. Eur Respir J 1998;12:46:370.
70. Slater JE, Paupore EJ, Elwell MR, et al. Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5. J Allergy Clin Immunol 1998;102: 977-983.
71. Hahn DL, Dodge R, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991;266:225-230.
72. Grayston JT, Kuo C-C, Wang S-P, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-168.
73. Cles LD, Stamm WE. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1990; 28:938-940.
74. Roblin PM, Dumornay W, Hammerschlag MR. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992;30:1968-1971.
75. Kuo C-C, Grayston JT. Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol 1988;26:812-815.
76. Kuo C-c. Chlamydia pneumoniae: culture methods. In: Allegra L and Blasi F, eds. Chlamydia pneumoniae: the lung and the heart. Milano: Springer-Verlag, 1999:9-15.
77. Falck G, Gnarpe J, Gnarpe H. Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections. Pediatr Infect Dis J 1997;16:549-554.
78. Falck G, Engstrand I, Gad A, et al. Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis 1997;29:585-589.
79. Khan MA, Potter CW, Sharrard RM. A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J Antimicob Chemother 1996;37:677-685.
80. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994;32:903-905.
81. Boman J, Allard A, Persson K, et al. Rapid diagnosis of Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 1997;175: 1523-1526.
82. Jantos CA, Roggendorf R, Wuppermann FN, et al. Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. J Clin Microbiol 1998;36:1890-1894.
83. Gnarpe J, Lundbäck A, Gnarpe H, et al. Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reaction. Scand J Infect Dis 1997;104:11-12.
84. Prückl PM, Aspock C, Makristathis A, et al. Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children. Eur J Clin Microbiol Infect Dis 1995;14:141-144.
85. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-588.
86. Wang SP, Grayston JT. Microimmunofluorescence serological studies with the TWAR organism. In: Oriel D, Ridgeway G, eds. Chlamydial infections: Proceedings of the Sixth International Symposium on Human Chlamydial Infections. Cambridge, Cambridge University Press, 1986:329-332.
87. Wang S-P, Grayston JT. The similarity of Chlamydia pneumoniae (TWAR) isolates as antigen in the microimmunofluorescence (MIF) test. In: Orfila J, Byrne GI, Chernesky MA, et al, eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994: 181-184.
88. Wang SP, Grayston JT. Chlamydia pneumoniae (TWAR) microimmunofluorescence antibody studies - 1998 update. In: Stephens RS, Byrne GI, Christiansen G, et al, eds. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. Napa, California. 1998:155-158.
89. Peeling RW, Wang SP, Grayston JT, et al. Chlamydia serology: inter-laboratory variation in microimmunofluorescence results. In: Stephens RS, Byrne GI, Christiansen G, et al, eds. Proceedings of the Ninth International Symposium on Human Chlamydial Infection. Napa, California. 1998:159-162.
90. Mordhorst CH, Wang SP, Grayston JT. Epidemic "ornithosis" and TWAR infection, Denmark, 1976-85. In: Oriel D and Ridgeway G, eds. Chlamydial infections: Proceedings of the Sixth International Symposium on Human Chlamydial Infections. Cambridge, Cambridge University Press, 1986:325-328.
91. Frydén A, Kihlström E, Mailer R, et al. A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis 1989;21:681-691.
92. Leinonen M, Linnanmäki E, Mattila K, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microbiol Pathogen 1990; 9:67-73.
93. Saikku P. Diagnosis of acute and chronic Chlamydia pneumoniae infections. In: Orfila J, Byrne GI, Chemesky MA, et al, eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994:163-172.
94. Tomasi TB, Grey HM. Structure and function of immunoglobulin A. Progr Allergy 1972;16:81-213.
95. Grayston JT, Golubjatnikov R, Hagiwara T, et al. Serologic tests for Chlamydia pneumoniae. Pediatr Infect Dis J 1993;12: 790-791.
96. Grayston JT. Chlamydia pneumoniae, strain TWAR. Chest 1989;95:664-669.
97. Grayston JT, Kuo C-C, Wang S-P, et al. Clinical findings in TWAR respiratory tract infections. In: Oriel D, Ridgeway G, eds. Chlamydial infections: Proceedings of the Sixth International Symposium on Human Chlamydial Infections. Cambridge, Cambridge University Press, 1986:337-340.
98. File TM, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophilia in respiratory infection. Infect Dis Clin North Am 1998;12: 569-592.
99. Thom DH, Grayston JT, Wang S-P, et al. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol 1990;132:248-256.
100. Thom DH, Grayston JT, Campbell LA, et al. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infec Dis 1994;13:785-792.
101. Grayston JT, Aldous M, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168:1231-1235.
102. Ekman M-R, Grayston IT, Visakorpi R, et al. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993;17:420-425.
103. Tsumura N, Yamada S, Kutlin A, et al. Chlamydia pneumoniae lower respiratory tract infections in Japanese children (Abstract K57). Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, American Society for Microbiology, 1995; 297.
104. Hagiwara K, Tashiro N, Ouchi K. Outbreak of Chlamydia pneumoniae infection in a junior high school (its symptomatology and detection of C. pneumoniae by PCR) (Abstract K40). Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, American Society for Microbiology, 1995:294.
105. Block S, Hedrick I, Hammerschlag M, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-477.
106. Aldous MB, Wang SP, Foy HM, et al. Chamydia pneumoniae infection in Seattle children and families. Am J Epidemiol 1990; 132:802.
107. Kutlin A, Roblin PM, Hammerschlag MR. Antibody response to Chlamydia pneumoniae infection in children with respiratory illness. J Infect Dis 1998;177:720-724.
108. Hahn D. Incident wheezing and prevalent asthma have different serologic patterns of "acute" Chlamydia pneumoniae antibodies in adults. Proceedings of the Third Meeting of the European Society for Chlamydia Research, Vienna, Austria, Società Editrice Esculapio, Bologna, 1996:226.
109. Hammerschlag MR. Chlamydia pneumoniae infections. Pediatr Infect Dis J 1993;12: 260-261.
110. Hahn DL, Emre U, Hammerschlag M. Antichlamydial antimicrobial therapy for asthma. Arch Pediatr Adolesc Med 1995;149: 219-220.
111. Kalayoglu MV, Hahn DL, Byrne GI. Chlamydia infection and pneumonia. In: Paradise LJ, Friedman H, Bendinelli M, eds. Opportunistic intracellular bacteria and immunity. New York: Plenum Press, 1999:233-253.
112. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
113. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116:273-278.
114. Grayston JT. Chlamydia pneumoniae and atherosclerosis. Rev Méd Interne 1996;17(1): 45s-47s.
115. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-349.
116. Nyström-Rosander C, Hultén K, Gustavsson I, et al. Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations. Scand J Infect Dis 1997;29:513-516.
117. Thom DH, Grayston JT. Chlamydia pneumoniae strain TWAR infections: descriptions, diagnosis, and treatment. Mediguide Infect Dis 1990;10:1-4.
118. Gupta S, Kaski JC. Open and controlled intervention trials for "unusual" anti-Chlamydia pneumoniae indications: antibiotic treatment in atherosclerosis and myocardial infarction. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae: the lung and the heart. Milano: Springer-Verlag, 1999:178-184.
119. Kawane H. Chlamydia pneumoniae. Thorax 1993;48:871.
120. Hahn DL. Infection as a cause of asthma. Ann Allergy 1994;73:276.
121. Thom DH, Grayston JT, Campbell LA, et al. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 1994;13:785-792.
122. Thom D. Lower respiratory tract infection with Chlamydia pneumoniae. Arch Fam Med 1994;3:828-832.
123. Aldous MB, West S, Kimaro DN, et al. Chlamydia pneumoniae (TWAR) infection in Tanzanian children. Trop Doctor 1996;26: 18-19.
124. Normann E, Gnarpe J, Gnarpe H, et al. Chlamydia pneumoniae in children with acute respiratory tract infections. Acta Pædiatr 1998;87:23-27.
125. Hyman CL, Roblin PM, Gaydos C, et al. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995;20:1174-1178.
126. Gnarpe J, Gnarpe H, Sundelöf B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand J Infect Dis 1991;23:387-388.
127. Korppi M, Leinon M, Koskela M, et al. Bacterial infection in under school age children with expiratory difficulty. Pediatr Pulmonol 1991;10:254-259.
128. Hahn DL, Golubjatnikov R. Asthma and chlamydial infection: a case series. J Fam Pract 1994;38:589-595.
129. Resta O, Monno R, Saracino A, et al. Chlamydia pneumoniae infection in Italian patients. Monaldi Arch Chest Dis 1995;50: 173-176.
130. Korppi M, Leinon M, Saikku P. Chlamydial infection and reactive airway disease. Arch Pediatr Adolesc Med 1995;149:341-342.
131. Gnarpe J, Gnarpe H, Normann E, et al. Chlamydia pneumoniae, Mycoplasma pneumoniae and Mycoplasma fermentons PCR in children with acute respiratory tract infections (Abstract C-160). Abstracts of the 96th General Meeting of the American Society for Microbiology, New Orlean, Louisiana, May 19-23, 1996;29.
132. Biscione GL, Xie P, Johnson A-WBR, et al. Prevalence of Chlamydia pneumoniae (CP) in children admitted to hospital with acute respiratory illness using PCR. Eur Respir J 1998;12(28):148S-149S.
133. Kamesaki S, Suehiro Y, Shinomiya K, et al. Chlamydia pneumoniae infection in children with asthma exacerbation. Jpn J Allergol 1998;47:667-673.
134. Björnsson E, Helm E, Janson C, et al. Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand J Infect Dis 1996;28:63-69.
135. von Hertzen L, Töyrlä M, Gimishanov A, et al. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. In: Stephens RS, Byrne GI and Christiansen G, et al, eds: Proceedings of the Ninth International Symposium on Human Chlamydial Infection. Napa, California, 1998:171-174.
136. Hahn DL, Allegra L. Chlamydia pneumoniae: a new possible cause of asthma. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae: the lung and the heart. Milano: Springer-Verlag, 1999:114-123.
137. Hahn DL. Infectious asthma: a reemerging clinical entity? J Fam Pract 1995;41: 153-157.
138. Hahn DL, McDonald R. Infectious asthma and Chlamydia pneumoniae IgA antibody. Wisc Med J 1995;94:682.
139. Weiss S, Quist J, Roblin P, et al. The relationship between Chlamydia pneumoniae and bronchospasm in adults (Abstract K39). Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, American Society for Microbiology, 1995; 294.
140. Cook PJ, Davies P, Tunnicliffe W, et al. Chlamydia pneumoniae and asthma. Thorax 1998;53:254-259.
141. Blasi F, Allegra L, Tarsia P, et al. Chlamydia pneumoniae and asthma. Thorax 1998;53: 1095-1096.
142. Hahn DL, Rekha G. Regional variation in ischemic heart disease: a possible missing risk factor? J Clin Epidemiol 1993;46: 668-669.
143. Kern DG, Neill MA, Schacter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest 1993;104:208-213.
144. Grayston JT, Campbell LA, Kuo C-C, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161:618-625.
145. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscl Thromb 1992;12:945-947.
146. Beaty CD, Grayston JT, Wang S-P, et al. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;144:1408-1410.
147. Hahn DL, Kern DG, Neill MA. Chlamydia pneumoniae. Chest 1994;105:1914-1915.
148. Cook PJ, Honeybourne D, Wise R, et al. Chlamydia pneumoniae antibody litres are significantly associated with the use of steroid medication in respiratory disease [Abstract]. Thorax 1996;51:S53.
149. Peters BS, Thomas B, Marshall B, et al. The role of Chlamydia pneumoniae in acute exacerbations of asthma. Am J Respir Crit Care Med 1994;149:A341.
150. Emre U, Sokolovskaya N, Roblin P. et al. Detection of Chlamydia pneumoniae-IgE, in children with reactive airway disease. J Infect Dis 1995;172:265-267.
151. Emre U, Bernius M, Roblin P, et al. Chlamydia pneumoniae infection in patients with cystic fibrosis. Clin Infect Dis 1996;22: 819-823.
152. Hahn DL, McDonald RA. Association of serum IgA antibody against Chlamydia pneumoniae with "infectious" asthma (Abstract C-152). 96th General Meeting of the Amerlean Society for Microbiology, 1996, New Orleans, Louisiana, May 19-23, 1996;29.
153. Brüggen H, Kaspar P, Petro W. Significance of TWAR-antigen immunofluorescence test and serologic chlamydia anti-rLPS antibody test results compared with clinical findings in asthmatic patients. Proceedings of the Third Meeting of the European Society for Chlamydia Research, Vienna, Austria, Società Editrice Esculapio, Bologna, 1996;227.
154. Miyashita N, Kubota Y, Nakajima M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998;80:405-409.
155. Blasi F, Cosentini R, Dal Negro R, et al. Chlamydia pneumoniae infection in adult asthmatic patients [Abstract]. Eur Resp J 1998;12:47s.
156. Blasi F, Denti F, Raccanelli R, et al. Chlamydia pneumoniae seroprevalence and smoking status in COPD patients. Am Rev Respir Crit Care Med 1995;151:A466.
157. Karvonen M, Tuomilehto J, Pitkäniemi J, et al. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994;23:1315-1321.
158. Paltiel O, Kark JD, Leinonen M, et al. High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol Infect 1995;114:465-473.
159. Linnanmäki E, Leinonen M, Mattila K, et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87: 1130-1134.
160. Lorenz J. Chlamydia pneumoniae: an important pathogen in chronic bronchitis. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae: the lung and the heart. Milano: Springer-Verlag, 1999:124-133.
161. Allegra L, Blasi F, Cosentini R. Perspectives and perceptions on the clinical relevance of Chlamydia pneumoniae infection. In: Allegra L, Blasi F, eds. Chlamydia pneumoniae: the lung and the heart. Milano: Springer-Verlag, 1999:204-205.
162. Blasi F, Legnani D, Lombarde VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993;6: 19-22.
163. von Hertzen L, Leinonen M, Surcel HM, et al. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol 1995;2: 454-457.
164. von Hertzen L, Isoaho R, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996;25:658-664.
165. von Hertzen L, Alakärppä H, Koskinen R, et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 1997;118: 155-164.
166. Miyashita N, Niki Y, Nakajima M, et al. Chlmydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 1998;114:969-971.
167. Hahn DL. Acute asthmatic bronchitis: a new twist to an old problem. J Fam Pract 1994;39: 431-435.